APhA ENDORSES FULL BAN ON DRUG SAMPLING
Executive Summary
APhA ENDORSES FULL BAN ON DRUG SAMPLING as one of three resolutions adopted at a May 25 board meeting. Approving a motion to support "legislation that would ban drug product sampling," the pharmacy association is setting the foundation for any attempts to raise the topic of sampling as part of the larger Capitol Hill consideration of health care reform proposals. Sen. Kassebaum (R- Kan.) and Rep. Brewster (D-Okla.) remain interested in introducing bills to ban sampling after Congress returns from the Memorial Day recess.